Warren Eric (CIK 0001916048)

Latest company ownership

ESPR - Esperion Therapeutics, Inc.
Role: Chief Commercial Officer
Shares held
370,218
Last filed at
Apr 21, 2025
Confidence Score
50.0
2026Q1
Confidence Score History
2022Q2 2026Q1

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Apr 17, 2025 Apr 21, 2025 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 52.5 -108 -0.03% ✗ $105.6
Mar 18, 2025 Mar 19, 2025 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 37.5 -2,433 -0.65% ✗ $3.6K
Feb 19, 2025 Feb 20, 2025 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 52.5 -239 -0.15% ✗ $446.5
Jan 17, 2025 Jan 21, 2025 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 52.5 -123 -0.08% ✗ $278
Dec 17, 2024 Dec 18, 2024 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 27.5 -2,234 -1.38% ✗ $5.4K
Nov 19, 2024 Nov 20, 2024 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 52.5 -197 -0.12% ✗ $426.5
Oct 17, 2024 Oct 18, 2024 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 52.5 -107 -0.07% ✗ $226.7
Sep 17, 2024 Sep 18, 2024 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 27.5 -2,608 -1.58% ✗ $4.7K
Aug 19, 2024 Aug 20, 2024 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 52.5 -211 -0.13% ✗ $410.6
Jul 17, 2024 Jul 19, 2024 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 52.5 -108 -0.07% ✗ $279.4
Jun 18, 2024 Jun 20, 2024 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 27.5 -2,540 -1.51% ✗ $7.3K
May 17, 2024 May 20, 2024 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 52.5 -192 -0.11% ✗ $476.7
Sep 20, 2023 Sep 21, 2023 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 27.5 -742 -1.07% ✗ $923.8
Aug 18, 2023 Aug 21, 2023 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 45.0 -243 -0.35% ✗ $343.6
Jul 19, 2023 Jul 20, 2023 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 52.5 -106 -0.15% ✗ $168
Jun 21, 2023 Jun 22, 2023 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 37.5 -603 -0.86% ✗ $894.3
May 17, 2023 May 18, 2023 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 45.0 -219 -0.31% ✗ $355.7
Apr 19, 2023 Apr 20, 2023 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 52.5 -115 -0.16% ✗ $147
Mar 17, 2023 Mar 20, 2023 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 37.5 -526 -0.74% ✗ $937.5
Mar 7, 2023 Mar 8, 2023 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 26.3 -5,090 -9.49% ✗ $25.7K
Oct 18, 2022 Oct 19, 2022 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 52.5 -107 -0.20% ✗ $822.8
Sep 19, 2022 Sep 20, 2022 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 45.0 -255 -0.47% ✗ $1.8K
Aug 31, 2022 Aug 31, 2022 Esperion Therapeutics, Inc. Chief Commercial Officer Buy 77.5 +1,000 1.89% ✗ $7.5K
Aug 17, 2022 Aug 18, 2022 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 45.0 -199 -0.37% ✗ $1.4K
Jul 19, 2022 Jul 20, 2022 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 37.5 -431 -0.80% ✗ $2.8K
Jun 17, 2022 Jun 21, 2022 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 45.0 -256 -0.47% ✗ $1.3K
May 17, 2022 May 18, 2022 Esperion Therapeutics, Inc. Chief Commercial Officer Sell 45.0 -196 -0.36% ✗ $1.2K